Pacific Biosciences of California, Inc. Restricted Cash and Cash Equivalents
Pacific Biosciences of California, Inc. (PACB) had Restricted Cash and Cash Equivalents of $1.60 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-06
- 2026-06-30: Restricted Cash and Cash Equivalents $1.60M.
- 2026-03-31: Restricted Cash and Cash Equivalents $1.59M.
- 2025-12-31: Restricted Cash and Cash Equivalents $1.55M.
- 2025-09-30: Restricted Cash and Cash Equivalents $1.83M.
| Period end | Restricted Cash and Cash Equivalents | Restricted Cash and Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $1.60M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.59M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.55M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $1.83M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.83M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $2.22M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $2.22M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $2.22M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $2.26M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $2.72M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $2.72M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $2.72M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $2.72M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $3.22M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $3.22M 10-K · filed 2025-03-17 | |
| 2022-09-30 | $3.22M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $3.22M 10-Q · filed 2023-08-04 | |
| 2022-03-31 | $5.48M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $5.09M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $5.06M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $3.30M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $4.34M 10-Q · filed 2022-05-06 | |
| 2020-12-31 | $4.34M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $3.50M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $3.50M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $4.00M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $4.30M 10-K · filed 2022-02-28 | $4.00M 10-K · filed 2020-02-28 |
| 2019-09-30 | $4.00M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $4.00M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $4.50M 10-Q · filed 2020-05-08 | |
| 2018-12-31 | $4.80M 10-K · filed 2021-02-26 | $4.50M 10-K · filed 2019-02-26 |
| 2018-09-30 | $4.50M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $4.50M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $4.50M 10-Q · filed 2019-05-03 | |
| 2017-12-31 | $4.50M 10-K · filed 2020-02-28 | |
| 2017-09-30 | $4.50M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $4.50M 10-Q · filed 2018-08-03 | |
| 2017-03-31 | $4.50M 10-Q · filed 2018-05-02 | |
| 2016-12-31 | $4.50M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |